Old CIC Events
10/07/2025
RAS-PI3K signalling regulates myCAF phenotype acquisition to modulate tumour progression
Marta Alcón — Centro de Investigación del Cáncer (CSIC-Universidad de Salamanca)
07/07/2025
Uncovering cancer vulnerabilities through novel non-coding, multidimensional, and phenotypic screening technologies
Juan José Montero Valderrama — Institute of Molecular Oncology and Functional Genomics (IMO), Technical University of Munich (TUM). Munich
03/07/2025
The long journey to develop a drug against an “undruggable” target in cancer
Laura Soucek — Vall d´Hebron, Barcelona
30/06/2025
Antibody-Drug Conjugates Targeting EGFR in Ovarian Cancer
Sheila Almaraz — Centro de Investigación del Cáncer (Universidad de Salamanca - CSIC)
19/06/2025
Structure of Centromeric Chromatin and Its Consequences for Genome Stability
Carlos Sacristán López — Hubrecht Institute, Utrech (Netherlands)
16/06/2025
Metabolic Control of Cell Fate in Regeneration and Cancer
Almudena Chaves Pérez — Memorial Sloan Kettering Cancer Centre (NY)
13/06/2025
defensa de tesis: Unraveling the role of RNA modifications in immune evasion and tumor progression in prostate cancer
Ana Macrina Añazco Guenkova — Programa de doctorado de biociencias: biología y clínica de cáncer
05/06/2025
Dissecting metastatic Bladder Cancer
Jesús M Paramio — CIEMAT and Inst Inv Biomed Univ Hosp “12 de Octubre”
29/05/2025
Defining mechanisms of genomic evolution in cancer
Sarah McClelland, PhD — Barts Cancer Institute, Queen Mary University of London
22/05/2025
Academic model for CAR-T development: ARI0002h for multiple myeloma and beyond
Carlos Fernández de Larrea — Hospital Clínic de Barcelona
